Skip to main content
PYPD logo

PolyPid Ltd.

PYPDNASDAQHealthcareBiotechnology

$4.75Today:- (-)1Y +49.85%

As of Oct 16, 2026 close

Market cap
$110.92M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.10$5.73
Volume (live)
-
Avg. volume (3M)
94.28K

PolyPid (PYPD) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), PolyPid reported total assets of $22.31M and total liabilities of $11.33M. Shareholders' equity was $10.97M, up 42.8% from $7.68M a year earlier. Total debt stood at $2.80M against $12.93M in cash and short-term investments, a net cash position of $10.14M. That puts debt-to-equity at 0.25, compared with 0.97 a year earlier.

PolyPid Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for PolyPid Ltd. (PYPD) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents6.4015.645.318.559.824.323.947.333.91
Short-Term Investments6.530.000.004.0422.3840.1622.690.0014.03
Cash & Short-Term Investments12.9315.645.3112.5932.2044.4826.627.3317.94
Accounts Receivable0.000.170.000.300.600.140.020.020.03
Inventory1.110.000.000.000.000.000.35-0.020.00
Other Current Assets1.190.930.110.542.612.590.420.460.76
Total Current Assets15.2316.576.0714.1934.8147.2027.418.0318.73
Non-Current Assets
Property, Plant & Equipment (Net)6.778.379.2211.688.765.896.126.192.93
Long-Term Investments0.000.000.000.000.000.000.200.220.00
Other Non-Current Assets0.310.280.090.100.6622.760.030.041.33
Total Non-Current Assets7.088.659.3111.789.4228.656.356.454.25
Total Assets22.3125.2215.3725.9744.2475.8533.7714.4822.98
Current Liabilities
Accounts Payable2.862.410.771.144.140.971.581.132.02
Short-Term Debt2.156.794.004.020.000.000.000.000.00
Current Portion of Long-Term Debt0.996.794.004.02-----
Accrued Liabilities2.732.571.952.413.94----
Deferred Revenue0.000.000.000.000.270.240.000.000.00
Other Current Liabilities2.730.020.020.020.011.661.002.561.35
Total Current Liabilities7.7412.687.298.558.082.882.583.693.36
Non-Current Liabilities
Long-Term Debt0.650.636.387.570.000.000.000.000.00
Other Non-Current Liabilities2.952.940.400.290.200.190.2592.51107.67
Total Non-Current Liabilities3.604.8610.1811.590.200.190.2592.51108.27
Total Liabilities11.3317.5417.4720.148.283.072.8396.19111.63
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.130.130.13
Retained Earnings-301.50-267.33-238.31-214.44-174.89-132.29-93.30-86.40-92.32
Accumulated Other Comprehensive Income0.000.000.000.000.000.00-2.12-1.18-0.77
Additional Paid-in Capital312.47275.02236.21220.27210.85205.065.67-63.48-59.22
Shares Outstanding18.2010.191.650.660.63----
Total Stockholders' Equity10.977.68-2.105.8335.9672.7830.94-81.71-88.65
Total Liabilities & Equity22.3125.2215.3725.9744.2475.8533.7714.4822.98

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About PolyPid Balance Sheet

How much debt does PolyPid have?

PolyPid had total debt of $2.80M as of Dec 31, 2025, against $12.93M in cash and short-term investments. Its debt-to-equity ratio was 0.25. Total debt was $7.42M a year earlier.

What are PolyPid's total assets?

PolyPid reported total assets of $22.31M as of Dec 31, 2025, down 11.6% from $25.22M a year earlier. Total liabilities were $11.33M.

What is PolyPid's shareholders' equity?

PolyPid's shareholders' equity was $10.97M as of Dec 31, 2025, or about $0.60 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition